Clinical studies recruiting near Nanning

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre
Phase 3 · The First Affiliated Hospital of Guangxi University of Chine · Tasly Pharmaceutical Group Co., Ltd · NCT07687186 A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Guangxi Medical University Affiliated Tumor Hospital · Eli Lilly and Company · NCT07218380 This Study is a FIH Study Which is Required to Understand the PK Characteristics, MTD, RP2D and Safety Profile.
Phase 1 · The First Affiliated Hospital of Guangxi Medical University · Nanjing RegeneCore Biotech Co., Ltd. · NCT06756451 Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Phase 3 · Guangxi Medical University Affiliated Tumor Hospital · Daiichi Sankyo · NCT07022483 Neoadjuvant vs Adjuvant in Locally Advanced Recurrent NPC
Phase 3 · The People's Hospital of Guangxi Zhuang Autonomous Region · Eye & ENT Hospital of Fudan University · NCT06235203 A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · Guangxi Medical University Affiliated Tumor Hospital ( Site · Merck Sharp & Dohme LLC · NCT06136559 IC Plus Low-dose Radiation Plus Cadonilimab in LANPC
Phase 3 · The First Affiliated Hospital of Guangxi Medical University · Sun Yat-sen University · NCT05941741 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Guangxi Medical University Affiliated Tumor Hospital · Pfizer · NCT06758401 Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Mod
Phase 3 · The First Affiliated Hospital of Guangxi Medical University · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06682169 PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
Phase 2 · The First People's Hospital of Nanning · Boehringer Ingelheim · NCT07355296 A Clinical Trial of TQ05105 Tablets in the Treatment of Chronic Graft-versus-host Disease
Phase 2 · The First Affiliated Hospital of Guangxi Medical University · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06300320 A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer
Phase 1/Phase 2 · Guangxi University Affiliated Hospital · Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharm · NCT06431490 A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multi
Phase 1 · Shanghai Henlius Biotech · NCT07160335 The Chinese Familial Alzheimer's Network
Phase N/A · First Affiliated Hospital of Guangxi Medical University · Capital Medical University · NCT03657732 A Study of DC50292A Tablet in Patients With MTAP-deleted Advanced or Metastatic Solid Tumors
Phase 1 · Guangxi Medical University Cancer Hospital · Heronova Pharmaceuticals · NCT07071090 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Guangxi Medical University Affiliated Tumor Hospital · Eli Lilly and Company · NCT06890598 A Phase I/IIa Study of AL8326 Combined With Toripalimab in the Treatment of Advanced Solid Tumors.
Phase 1/Phase 2 · The People's Hospital of Guangxi Zhuang Autonomous Region · Advenchen Laboratories, LLC · NCT07392736 A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · Research Site · AstraZeneca · NCT06868277 A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Phase 3 · The Second Affiliated Hospital of Guangxi Medical University · Eli Lilly and Company · NCT07369011 A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · Guangxi Medical University Affiliated Tumor Hospital · Pfizer · NCT07144280 A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymph
Phase 3 · Guangxi Medical University Affiliated Tumor Hospital · Loxo Oncology, Inc. · NCT05254743 A Study to Evaluate the Efficacy and Safety of IBI363 Monotherapy Compared to Pembrolizumab in Patients With Unresectabl
Phase 2 · Affiliated Tumor Hospital of Guangxi Medical University · Innovent Biologics (Suzhou) Co. Ltd. · NCT06797297 A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC278 in the Treatment of Solid Tumors
Phase 1/Phase 2 · Guangxi Medical University Cancer Hospital & Guangxi Cancer · RemeGen Co., Ltd. · NCT07105215 A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone
Phase 3 · Local Institution - 0240 · Celgene · NCT05519085 A Trial of SHR-A1811 Combined With Other Antitumor Therapies in Advanced Solid Tumors.
Phase 1/Phase 2 · Guangxi Medical University Affiliated Tumor Hospital · Jiangsu HengRui Medicine Co., Ltd. · NCT06015048 A Study of JAB-21822 in Advanced or Metastatic NSCLC With KRAS p.G12C and STK11 Co-mutation and Wild-type KEAP1
Phase 1/Phase 2 · Research site016 · Allist Pharmaceuticals, Inc. · NCT05276726 Clinical Trial Evaluating TQB6411 Injection in Participant s With Esophageal Cancer
Phase 1/Phase 2 · Guangxi Medical University Cancer Hospital · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT07367516 Edaravone in the Treatment of Optic Neuritis
NA · Yi Du · First Affiliated Hospital of Guangxi Medical University · NCT05540262 China HeadAche DIsorders RegiStry
Phase N/A · The First Affiliated Hospital of Guangxi University of Chine · Beijing Tiantan Hospital · NCT05334927 A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropath
Phase 3 · The First Affiliated Hospital of Guangxi Medical University · Biogen · NCT06962800

Look up another city

Look up another condition